Insulet (PODD) Operating Expenses (2016 - 2025)
Insulet (PODD) has disclosed Operating Expenses for 16 consecutive years, with $422.4 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Operating Expenses rose 31.34% year-over-year to $422.4 million, compared with a TTM value of $1.5 billion through Dec 2025, up 28.97%, and an annual FY2025 reading of $1.5 billion, up 28.97% over the prior year.
- Operating Expenses was $422.4 million for Q4 2025 at Insulet, up from $392.4 million in the prior quarter.
- Across five years, Operating Expenses topped out at $422.4 million in Q4 2025 and bottomed at $37.5 million in Q3 2021.
- Average Operating Expenses over 5 years is $223.5 million, with a median of $236.2 million recorded in 2023.
- The sharpest move saw Operating Expenses dropped 3.35% in 2021, then skyrocketed 441.15% in 2022.
- Year by year, Operating Expenses stood at $41.8 million in 2021, then skyrocketed by 363.64% to $193.8 million in 2022, then skyrocketed by 31.42% to $254.7 million in 2023, then grew by 26.27% to $321.6 million in 2024, then skyrocketed by 31.34% to $422.4 million in 2025.
- Business Quant data shows Operating Expenses for PODD at $422.4 million in Q4 2025, $392.4 million in Q3 2025, and $331.1 million in Q2 2025.